TREATMENT WITH ANTI-SARS-COV-2 IMMUNOGLOBULIN IN PATIENTS WITH COVID-19
Clinical trial NCT04573855 · UNKNOWN
Trial details
- NCT number
- NCT04573855
- Sponsor
- D'Or Institute for Research and Education
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-01
- Primary completion
- 2021-02-28
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.